# Wearable Technology to Evaluate Hyperglycemia and HRV in DMD

> **NCT06124196** · — · RECRUITING · sponsor: **Vanderbilt University Medical Center** · enrollment: 80 (estimated)

## Conditions studied

- Duchenne Muscular Dystrophy

## Interventions

- **DEVICE:** wearable technology

## Key facts

- **NCT ID:** NCT06124196
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-20
- **Primary completion:** 2030-02
- **Final completion:** 2031-02
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2025-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06124196

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06124196, "Wearable Technology to Evaluate Hyperglycemia and HRV in DMD". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06124196. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*